News and Comments


  Wednesday, December 18, 2013

When Amgen (AMGN) develops a drug, the wise King does whatever it takes to squeeze every drop of its therapeutic capability before submitting the new drug application (NDA) to the FDA for approval. The firm is rich in its science, scientists, pipeline of investigational products and its approved products. All the problems the firm encountered that analysts believed would erode its fortune, such as limiting the use of its growth factors did not impact the firm’s growth, but unveiled the character and culture that made the king deserve its throne.   More...


  Monday, December 09, 2013

Taking down Gilead (GILD) seems to be beyond the reach authors of tales intended to frighten investors into selling this outstanding stock. The attempts have been repetitive but short of success. Gilead is a stallion. Unlike stallions, the horses whose muscular superiority over other horses is genetically derived, Gilead’s power is acquired through a unique culture that embraces the power of intuition, self-confidence, common sense and courage. Using an optimal amount of faith, the firm turned intuition into inspiration and using courage and wisdom, the Stallion carried out inspired tasks fated unattainable by others.  More...

Recent Postings



IDERA (IDRA) Roche (RHHBY) VANDA (VNDA) Endometrial Cancer AERIE PHARMACEUTICALS Genentech Intermune (ITMN) Agenus (AGEN Regeneron (REGN) Gilead (GILD) Rapamune ARCA (ABIO) SUNESIS PHARMACEUTICALS (SNSS) Adaptimmune (ADAP) OncoCyte (OCX) Prolor Biotech (PBTH) Herceptin Multiple Myeloma Exelixis (EXEL) Theravance (THRX) REGULUS (RGLS) GUARDIAN HEALTH Aimmune Therapeutics (AIMT) Revlimid (lenolidamide) NOVOCURE (NVCR) HALOZYME (HALO) Biocryst (BCRX) Valeant Pharmaceuticals International (VRX) NANTKWEST (NK) OSI (OSIP) AstraZeneca (AZN) Intrexon (XON) Human Genome Sciences (HGSI) Ocular Therapeutix (OCUL) Xoma (XOMA) GlaxoSmithKline (GSK) Telaprevir Inovio (INO) Array Pharmaceuticals (ARRY) Jazz Pharmaceuticals (JAZZ) SYNTA (SNTA) Benlysta (belimumab) Agenus (AGEN) Ziofpharm (ZIOP) ISIS (ISIS) INNOVIVA (INVA) ZALTRAP™ CEMPRA (CEMP) Vertex (VRTX) ADVENTRIX (ANX) Sequenom (SQNM) JOUNCE THERAPEUTICS (JNCE) Idenix (IDIX) CRISPR Therapeutics (CRSP) JUNO (JUNO) Micromet (MITI) Advaxis (ADXS) SERES THERAPEUTICS (MCRB) Mirati Therapeutics (MRTX) Velcade (bortezomib) Theravance Bio Pharma (TBPH) ACADIA (ACAD) ABBVIE (ABBV) ImmunoGen (IMGN) Pluristem (PSTI) LEXICON (LXRX) AGOS (ARGS) Biogen Idec (BIIB) PTC Therapeutics (PTCT) Merck (MRK) Ariad (ARIA) CompuGen (CGEN) Auspex (ASPX) Dendreon (DNDN) KERYX (KERX) Anadys (ANDS) Dynavax (DVAX) Prosensa (RNA) Alnylam (ALNY) Cytokinetics (CYTK) C4 Therapeutics KITE (KITE) Ridaforolimus Bristol-Myers Squibb (BMY) Galena (GALE) Global Cell Therapeutics (GBT) Intercept (ICPT) Editas (EDIT) galapagos (GLPG) Trastuzumab-DM1 NEUROCRINE (NBIX) NEKTAR (NKTR)) Abbott Laboratories (ABT) Human Longevity (HLI) Roche (ROCHE) Onyx (ONXX) Sanofi (SNY) Tysabri Zerenex MODERNA Illumina (ILMN) BIOMARIN (BMRN) Sarepta (SRPT) Vitae Pharmaceuticals (VTAE) Seattle Genetics (SGEN) Spike Therapeutics (ONCE) Sanofi-Aventis (SAN) Amgen (AMGN) Alder Biopharmaceuticals (ALDR) TOKAI (TKAOI) Bellicum (BLCM) Ionis (IONS) Incyte (INCY) RenenxBio (RGNX) Anacor (ANAC) Sangamo (SGMO) PORTOLA (PTLA) Elan (ELN) Sanofi (SNA) ARGOS (ARGS)